Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (E1WL34) Stock Price & Analysis

E1WL34 Stock Chart & Stats

R$104.50R$0.00(0.00%)

At close: Nov 03

Day’s Range: BRL 103.00 - BRL 131.95
52-Week Range: BRL 94.30 - BRL 131.95
Previous Close: BRL 104.50
Volume: N/A
Average Volume (3M): 0
Market Cap: BRL 295.07B
Enterprise Value: BRL 239.55B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 47048.8
Beta: -0.15
Next Earnings: Nov 04, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh News

Edwards Lifesciences reports Q3 adjusted EPS 80c, consensus 74c

Reports Q3 revenue $1.72B, consensus $1.68B. “We delivered strong third-quarter growth of 11.2% which exceeded expectations, with broad-based performance across our businesses and regions, giving us the confidence to raise

3h agoEW EWL

Edwards Lifesciences raises FY26 EPS view to $2.97-$3.05, consensus $2.96

As a result of the company’s strong third quarter results, Edwards is increasing its full-year 2026 sales growth rate guidance to approximately 11.5% from 10% to 11% and TAVR product

3h agoEW EWL

Edwards Lifesciences sees Q4 adjusted EPS 61c-69c, consensus 71c

Sees Q4 revenue $1.67B-$1.75B, consensus $1.7B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >>

3h agoEW EWL

Midday Fly By: Democrats win major victories, AMD reports upbeat Q3

The major averages were sharply higher following Tuesday’s midterm elections, as Democrats retook the Senate and House of Representatives and won multiple state governorships. The conclusion of the midterm elections,

7h agoEW KD

Adobe downgraded, Constellation upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by

10h agoAN EW

Edwards Lifesciences upgraded to Buy from Hold at Truist

Truist analyst Richard Newitter last night upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $113, up from $95. The firm says this week’s positive PROGRESS

15h agoEW EWL

Edwards Lifesciences upgraded to Buy from Hold at Truist

Truist upgraded Edwards Lifesciences (EW) to Buy from Hold with a $113 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

22h agoEW EWL

Edwards Lifesciences: PROGRESS Trial Supports TAVR Expansion in Selected Moderate Aortic Stenosis Patients

Edwards Lifesciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis Steed from Bank of America Securities maintained a Buy rating on the stock and

1d agoEW EWL

Edwards Lifesciences announces results from CLASP II TR trial of PASCAL system

Edwards Lifesciences (EW) announced that the PASCAL system for tricuspid repair demonstrated superiority compared to medical therapy alone for the six-month primary endpoint of the CLASP II TR trial. The

2d agoEW EWL

Edwards announced results from PROGRESS trial

Edwards Lifesciences (EW) announced results from the PROGRESS Trial in the management of moderate aortic stenosis. The trial demonstrated that transcatheter aortic valve replacement, or TAVR, was superior to clinical

2d agoEW EWL

Edwards Lifesciences added to ‘Core Ideas’ list at Evercore, Illumina removed

Evercore ISI raised the firm’s price target on Edwards Lifesciences (EW) to $102 from $100 and keeps an Outperform rating on the shares, which were also added to the firm’s

1w agoEW ILMN

CMS TAVR Coverage Expansion and Asymptomatic AS Inclusion Underpin Vazquez’s Buy Rating on Edwards Lifesciences

William Blair analyst Brandon Vazquez has maintained their bullish stance on EW stock, giving a Buy rating today. Brandon Vazquez has given his Buy rating due to a combination of

1M agoEW EWL

Balanced NTAP Tailwinds and Cautious TMTT Rollout Lead Plovanic to Maintain Hold Rating and Unchanged $85 Price Target on Edwards Lifesciences

Analyst William Plovanic from Canaccord Genuity maintained a Hold rating on Edwards Lifesciences and keeping the price target at $85.00. William Plovanic has given his Hold rating due to a

3M agoEW EWL

Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts

Canaccord Genuity analyst William Plovanic maintained a Hold rating on Edwards Lifesciences yesterday and set a price target of $85.00. William Plovanic has given his Hold rating due to a

3M agoEW EWL

E1WL34 FAQ

What was Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s price range in the past 12 months?

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh lowest stock price was R$94.30 and its highest was R$131.95 in the past 12 months.

What is Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s market cap?

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s market cap is R$295.07B.

When is Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s earnings last quarter?

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh released its earnings results on Jul 23, 2026. The company reported R$0.001 earnings per share for the quarter.

Is Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh pay dividends?

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh does not currently pay dividends.

What is Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s EPS estimate?

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh have?

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh has 2,305,600,000 shares outstanding.

What happened to Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh’s price movement after its last earnings report?

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh reported an EPS of R$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh?

Currently, no hedge funds are holding shares in BR:E1WL34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (E1WL34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Bearish
Overall Consensus	8	13
Technical Analysis	6	3
Moving Averages	2	10

Technical Analysis >

Similar Stocks

Stocks similar to BR:E1WL34
Company	Price & Change	Follow
BR:B1DX34Becton, Dickinson and Company Shs Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
BR:B1SX34Boston Scientific Corporation Unsponsored Brazilian Depositary Receipt Repr 1 Sh
BR:C1AH34Cardinal Health, Inc. Unsponsored Brazilian Depositary Receipt Repr 1 Sh
BR:C1CO34Cencora, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
BR:WATC34Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh

Compare BR:E1WL34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

E1WL34 Stock Chart & Stats

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh News

Edwards Lifesciences reports Q3 adjusted EPS 80c, consensus 74c

Edwards Lifesciences raises FY26 EPS view to $2.97-$3.05, consensus $2.96

Edwards Lifesciences sees Q4 adjusted EPS 61c-69c, consensus 71c

Midday Fly By: Democrats win major victories, AMD reports upbeat Q3

Adobe downgraded, Constellation upgraded: Wall Street’s top analyst calls

Edwards Lifesciences upgraded to Buy from Hold at Truist

Edwards Lifesciences upgraded to Buy from Hold at Truist

Edwards Lifesciences: PROGRESS Trial Supports TAVR Expansion in Selected Moderate Aortic Stenosis Patients

Edwards Lifesciences announces results from CLASP II TR trial of PASCAL system

Edwards announced results from PROGRESS trial

Edwards Lifesciences added to ‘Core Ideas’ list at Evercore, Illumina removed

CMS TAVR Coverage Expansion and Asymptomatic AS Inclusion Underpin Vazquez’s Buy Rating on Edwards Lifesciences

Balanced NTAP Tailwinds and Cautious TMTT Rollout Lead Plovanic to Maintain Hold Rating and Unchanged $85 Price Target on Edwards Lifesciences

Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts

E1WL34 FAQ

Edwards Lifesciences Corp Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (E1WL34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium